일성아이에스

003120KOSPI의약품 제조업

52.3 / 100

Reference Date: 2026-07-24

Financial Score15.0 / 40

News Sentiment13.3 / 25

Momentum14.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Rose 7.8% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Ilshin IS is a pharmaceutical company specializing in penicillin antibiotics, collaborating with GSK, and producing key products like Augmentin, which generated 15,404 million won in sales. The company develops and sells medications across endocrine, digestive, and circulatory systems, achieving 64,292 million won in domestic sales during the 66th fiscal year.

Number of Employees

194people

Average Salary

51.8M KRW

Score Calculation Basis

Detailed Financial Score

PER

121.76Industry Average 11.230.0Point

10.8x industry avg (risky)

PBR

0.71Industry Average 0.814.0Point

In line with industry avg

ROE

0.30Industry Average 4.011.0Point

Well below industry avg

Debt Ratio

0.31Industry Average 12.438.0Point

Half of industry avg (excellent)

Trend 2023~20252.0 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼9.2% (2-year basis)

Operating Profit Growth Rate

2.0 / 3

Avg ▲8.1% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -0.4% (improving, 3yr)

Detailed News Sentiment

10 totalPositive 1Neutral 8Negative 1Average Sentiment Score 53

Positive
GS건설, 5717억 용산 문배업무지구 복합개발 수주 [공시pick]
GS건설의 용산 문배업무지구 복합개발 수주로 인해 일성아이에스와 직접적인 연관성이 있는 GS건설의 성장 기대감이 높아짐.
Neutral
최태원 "일하는 방식 AI에 맞게 재설계해야 경제도 성장"
최태원 회장의 발언은 AI 혁신을 강조했으나, 직접적인 일성아이에스 주식 영향은 명시되지 않았습니다.
Neutral
최태원 "AI 도입, 일하는 방식 새로 짜야"…조정식 "경제대도약위 ...
최태원 회장의 AI 전환 강조는 대한상의 포럼에서 언급되었으나, 직접적인 일성아이에스의 영향은 제한적이다.

Detailed Momentum

52-week position3.0Point

52w lower range (21%)

Current 20,700Won52-week high 28,30052-week low 18,600

1-month return5.0Point

1m +7.81% (rising)

Volume trend6.0Point

Volume increasing

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0

Neutral최대주주등소유주식변동신고서2026-07-23
Neutral주식등의대량보유상황보고서(일반)2026-07-23
Neutral유형자산처분결정2026-07-14